Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
02-05 February, 2026
Not Confirmed
Not Confirmed
03-05 February, 2026
Paris Packaging WeekParis Packaging Week
Not Confirmed
Not Confirmed
05-06 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
02-05 February, 2026
Industry Trade Show
Not Confirmed
03-05 February, 2026
Paris Packaging WeekParis Packaging Week
Industry Trade Show
Not Confirmed
05-06 February, 2026
Digital content

27 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/27/3226375/35409/en/Cytokinetics-Announces-MYQORZO-aficamten-Now-Available-in-the-U-S-for-the-Treatment-of-Adults-with-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-to-Improve-Functional-Capacit.html

27 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/27/3226456/35409/en/Cytokinetics-and-Olympic-Gold-Medalist-Sydney-McLaughlin-Levrone-Team-Up-to-Raise-Awareness-of-the-Whole-Person-Impact-of-Hypertrophic-Cardiomyopathy-HCM.html

20 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/20/3222232/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

13 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orsini-selected-as-specialty-pharmacy-partner-for-cytokineticss-myqorzo-aficamten-302659745.html

12 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/12/3217380/0/en/CareMed-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Provider-for-MYQORZO-aficamten.html

05 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/05/3213171/35409/en/Cytokinetics-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE